Dillmann WH. Diabetic cardiomyopathy. Circ Res. 2019;124:1160–2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luo W, Lin K, Hua J, Han J, Zhang Q, Chen L, Khan ZA, Wu G, Wang Y, Liang G. Schisandrin B attenuates diabetic cardiomyopathy by Targeting MyD88 and inhibiting MyD88-dependent inflammation. Adv Sci (Weinh). 2022;9:e2202590.

Article  PubMed  Google Scholar 

Balakumar P, Maung-U K, Jagadeesh G. Prevalence and prevention of cardiovascular disease and diabetes mellitus. Pharmacol Res. 2016;113:600–9.

Article  PubMed  Google Scholar 

Hwang G-S, Yang J-Y, Ryu DH, Kwon T-H. Metabolic profiling of kidney and urine in rats with lithium-induced nephrogenic diabetes insipidus by (1)H-NMR-based metabonomics. Am J Physiol Renal Physiol. 2010;298:F461–70.

Article  CAS  PubMed  Google Scholar 

Sacramento JF, Chew DJ, Melo BF, Donegá M, Dopson W, Guarino MP, Robinson A, Prieto-Lloret J, Patel S, Holinski BJ, Ramnarain N, Pikov V, Famm K, Conde SV. Bioelectronic modulation of carotid sinus nerve activity in the rat: a potential therapeutic approach for type 2 diabetes. Diabetologia. 2018;61:700–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prasad R, Floyd JL, Dupont M, Harbour A, Adu-Agyeiwaah Y, Asare-Bediako B, Chakraborty D, Kichler K, Rohella A, Li Calzi S, Lammendella R, Wright J, Boulton ME, Oudit GY, Raizada MK, Stevens BR, Li Q, Grant MB. Maintenance of Enteral ACE2 Prevents Diabetic Retinopathy in Type 1 Diabetes. Circ Res. 2023;132(1):e1–21.

Article  CAS  PubMed  Google Scholar 

Tang Y, Zhang L, Ye D, Zhao A, Liu Y, Zhang M. Causal relationship between Type 1 diabetes and osteoporosis and fracture occurrence: a two-sample Mendelian randomization analysis. Osteoporos Int. 2023;34(6):1111–7.

Article  CAS  PubMed  Google Scholar 

Lavie CJ, Johannsen N, Swift D, Senechal M, Earnest C, Church T, Hutber A, Sallis R, Blair SN. Exercise is medicine - the importance of physical activity, exercise training, cardiorespiratory fitness and obesity in the prevention and treatment of type 2 diabetes. Eur Endocrinol. 2014;10:18–22.

Article  PubMed  PubMed Central  Google Scholar 

Jakicic JM, Jaramillo SA, Balasubramanyam A, Bancroft B, Curtis JM, Mathews A, Pereira M, Regensteiner JG, Ribisl PM, Look ASG. Effect of a lifestyle intervention on change in cardiorespiratory fitness in adults with type 2 diabetes: results from the look AHEAD Study. Int J Obes (Lond). 2009;33:305–16.

Article  CAS  PubMed  Google Scholar 

Perry AS, Dooley EE, Master H, Spartano NL, Brittain EL, Pettee Gabriel K. Physical activity over the lifecourse and cardiovascular disease. Circ Res. 2023;132:1725–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dunstan DW, Salmon J, Healy GN, Shaw JE, Jolley D, Zimmet PZ, Owen N. Association of television viewing with fasting and 2-h postchallenge plasma glucose levels in adults without diagnosed diabetes. Diabetes Care. 2007;30:516–22.

Article  CAS  PubMed  Google Scholar 

Hemmingsen B, Gimenez-Perez G, Mauricio D, I Figuls MR, Metzendorf M-I, Richter B. Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database Syst Rev. 2017;12:CD003054.

PubMed  Google Scholar 

Petermann F, Díaz-Martínez X, Garrido-Méndez Á, Leiva AM, Martínez MA, Salas C, Poblete-Valderrama F, Celis-Morales C. Association between type 2 diabetes and physical activity in individuals with family history of diabetes. Gac Sanit. 2018;32:230–5.

Article  PubMed  Google Scholar 

Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, Donahue K, Doubeni CA, Epling JW, Kubik M, Landefeld S, Ogedegbe G, Pbert L, Silverstein M, Simon MA, Tseng C-W, Wong JB. Behavioral counseling interventions to promote a healthy diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: US preventive services task force recommendation statement. JAMA. 2020;324:2069–75.

Article  PubMed  Google Scholar 

Balducci S, Sacchetti M, Haxhi J, Orlando G, D’Errico V, Fallucca S, Menini S, Pugliese G. Physical exercise as therapy for type 2 diabetes mellitus. Diabetes Metab Res Rev. 2014;30(Suppl 1):13–23.

Article  PubMed  Google Scholar 

Rao G, Peng B, Zhang G, Fu X, Tian J, Tian Y. MicroRNAs in diabetic macroangiopathy. Cardiovasc Diabetol. 2024;23:344.

Article  PubMed  PubMed Central  Google Scholar 

Halabi N, Thomas B, Chidiac O, Robay A, AbiNahed J, Jayyousi A, Al Suwaidi J, Bradic M, Abi Khalil C. Dysregulation of long non-coding RNA gene expression pathways in monocytes of type 2 diabetes patients with cardiovascular disease. Cardiovasc Diabetol. 2024;23:196.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meng L, Lin H, Huang X, Weng J, Peng F, Wu S. METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA. Cell Death Dis. 2022;13:38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dieter C, Lemos NE, Corrêa NRDF, Assmann TS, Crispim D. The impact of lncRNAs in diabetes mellitus: a systematic review and in silico analyses. Front Endocrinol (Lausanne). 2021;12:602597.

Article  PubMed  PubMed Central  Google Scholar 

Lu Y, Qie D, Yang F, Wu J. LncRNA MEG3 aggravates adipocyte inflammation and insulin resistance by targeting IGF2BP2 to activate TLR4/NF-κB signaling pathway. Int Immunopharmacol. 2023;121:110467.

Article  CAS  PubMed  Google Scholar 

Hu Z, Wang J, Pan T, Li X, Tao C, Wu Y, Wang X, Zhang Z, Liu Y, Zhang W, Xu C, Wu X, Gu Q, Fan Y, Qian H, Mugisha A, Yuan S, Liu Q, Xie P. The exosome-transmitted lncRNA LOC100132249 induces endothelial dysfunction in diabetic retinopathy. Diabetes. 2023;72:1307–19.

Article  PubMed  Google Scholar 

Chen K, Ou B, Huang Q, Deng D, Xiang Y, Hu F. LncRNA NEAT1 aggravates human microvascular endothelial cell injury by inhibiting the Apelin/Nrf2/HO-1 signalling pathway in type 2 diabetes mellitus with obstructive sleep apnoea. Epigenetics. 2024;19:2293409.

Article  PubMed  PubMed Central  Google Scholar 

Alharbi KS. GAS5: A pivotal lncRNA in diabetes mellitus pathogenesis and management. Pathol Res Pract. 2024;253:154955.

Article  CAS  PubMed  Google Scholar 

Xu Y, Kang X, Liu H, Jiang H, Wang W. LncRNA XIST promotes insulin resistance in gestational diabetes mellitus via the microRNA-181b-5p/NDRG2 axis. Gen Physiol Biophys. 2023;42:443–55.

Article  CAS  PubMed  Google Scholar 

Carter G, Miladinovic B, Patel AA, Deland L, Mastorides S, Patel NA. Circulating long noncoding RNA GAS5 levels are correlated to prevalence of type 2 diabetes mellitus. BBA Clin. 2015;4:102–7.

Article  PubMed  PubMed Central  Google Scholar 

Quaiyoom A, Kumar R. An overview of diabetic cardiomyopathy. Curr Diabetes Rev. 2024;20:e121023222139.

Article  CAS  PubMed  Google Scholar 

Nakamura K, Miyoshi T, Yoshida M, Akagi S, Saito Y, Ejiri K, Matsuo N, Ichikawa K, Iwasaki K, Naito T, Namba Y, Yoshida M, Sugiyama H, Ito H. Pathophysiology and treatment of diabetic cardiomyopathy and heart failure in patients with diabetes mellitus. Int J Mol Sci. 2022;23(7):3587.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res. 2018;122:624–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jia G, Whaley-Connell A, Sowers JR. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia. 2018;61:21–8.

Article  CAS  PubMed  Google Scholar 

Sung MM, Hamza SM, Dyck JR. Myocardial metabolism in diabetic cardiomyopathy: potential therapeu